Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, Korea.
Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 2022 Dec;63(12):1113-1120. doi: 10.3349/ymj.2022.0388.
To examine the risk of dental abnormalities after exposure to tetracycline and its derivatives (TCs) in Korean children.
Children aged 0-17 years with a claim for prescriptions of TCs between 2002 and 2015 were identified from the Sample Research Database 2.0 of the National Health Insurance Service. Children not exposed to TCs were selected as the control group by matching sex and age (1:4). Cumulative incidence rate and relative risk of dental abnormalities after TCs exposure were investigated.
The 10-year cumulative incidence rate in the 0-12 years group was 3.1% [95% confidence interval (CI), 2.3-3.9]. The 10-year cumulative incidence rates were 7.0%, 1.9%, and 1.6% in the 0-7, 8-12, and 13-17 years age groups (95% CI: 4.7-9.3, 1.2-2.6, and 1.3-1.9, respectively). There was no significant difference in the risk of dental abnormalities according to TC exposure among the age groups of 0-7 years [adjusted hazard ratio (aHR)=1.0], 8-12 years (aHR=1.1), and 13-17 years (aHR=1.2).
Short-term exposure to TCs does not appear to increase the risk of dental abnormalities in children aged 0-7 and 0-12 years. Restrictions on the use of TCs in children aged 8-12 years, in some countries, may warrant consideration.
研究韩国儿童接触四环素及其衍生物(TCs)后发生牙齿畸形的风险。
从国民健康保险服务抽样研究数据库 2.0 中筛选出 2002 年至 2015 年期间接受 TCs 处方的 0-17 岁儿童。通过性别和年龄(1:4)匹配选择未接触 TCs 的儿童作为对照组。调查 TCs 暴露后牙齿畸形的累积发生率和相对风险。
0-12 岁组的 10 年累积发生率为 3.1%(95%置信区间[CI]:2.3-3.9)。0-7、8-12 和 13-17 岁年龄组的 10 年累积发生率分别为 7.0%、1.9%和 1.6%(95%CI:4.7-9.3、1.2-2.6 和 1.3-1.9)。0-7 岁(调整后的危险比[aHR]=1.0)、8-12 岁(aHR=1.1)和 13-17 岁(aHR=1.2)年龄组之间 TCs 暴露与牙齿畸形风险无显著差异。
短期接触 TCs 似乎不会增加 0-7 岁和 0-12 岁儿童发生牙齿畸形的风险。在一些国家限制 8-12 岁儿童使用 TCs 可能需要考虑。